Moreover, the finding of PVR and ICAM-1 involvement in such a context provides new insight into the molecular mechanisms of NK cytotoxicity against CML-BC blasts. The gene discussed is PVR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.